BR55 in Characterization of Ovarian Lesions

Trial ID or NCT#

NCT03493464

Status

not recruiting iconNOT RECRUITING

Purpose

This is an exploratory phase II, single center, open label, prospective study of BR55 CEUS for characterization of ovarian lesions in subjects with suspected ovarian cancer.

Official Title

BR55 Contrast Enhanced Ultrasound (CEUS) in Characterization of Ovarian Lesions

Eligibility Criteria

Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Terry Desser

Contact us to find out if this trial is right for you.

Contact

Mahima Goel
650.723.0371

View on ClinicalTrials.gov